Simon Clark has joined Polpharma as vice-president of the management board and chief commercial officer...
Polpharma B2B has broad experience in complex chemistries and it offers custom contract development and manufacturing organization (CDMO) services for clients looking for a European manufacturing site for their active substances.
With dedicated project management and research and development (R&D) teams, a corporate quality system and service excellence, the company delivers tailored solutions to meet your every need.
Polpharma B2B’s strengths and expertise within CDMO include:
- Successful tracking of US Food and Drug Administration (FDA) inspections
- Development from lab to market
- Professional project management
- World-class regulatory service
- State-of-the-art R&D
- Current good manufacturing practice (cGMP) pilot plant
- Comprehensive experience
- Easy-access location
New requirements and guidelines appear every year that enforce higher product quality. In order to maintain the position of one of the best on the market, Polpharma B2B not only follows requirements but it is ahead of them.
This white paper outlines Polpharma B2B's finished dosage formulations (FDF) that are currently under development. Products...
Polpharma B2B is a significant European active pharmaceutical ingredient (API) producer with current good manufacturing...
Polpharma B2B's team of experts will be pleased to meet you at the CPhI Worldwide...